RT Journal Article
SR Electronic
T1 Barriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence
JF European Respiratory Review
JO EUROPEAN RESPIRATORY REVIEW
FD European Respiratory Society
SP 230066
DO 10.1183/16000617.0066-2023
VO 32
IS 169
A1 Tikellis, Gabriella
A1 Hoffman, Mariana
A1 Mellerick, Christie
A1 Burge, Angela T.
A1 Holland, Anne E.
YR 2023
UL http://err.ersjournals.com/content/32/169/230066.abstract
AB Background: Oxygen therapy is prescribed to treat hypoxaemia in people with interstitial lung disease (ILD); however, uptake and adherence remain an ongoing challenge. This systematic review aimed to identify the barriers to and facilitators of use of oxygen therapy in people with ILD, caregivers and health professionals.Methods: A systematic search for qualitative literature was undertaken using five electronic databases (MEDLINE, CINAHL, Embase, PsycINFO, PubMed). Qualitative analysis identified themes that were mapped to the Theoretical Domains Framework and the Consolidated Framework for Implementation Research and classified as barriers, facilitators or both.Results: A total of 13 studies were eligible for inclusion. Commonly represented domains were associated with the design of the oxygen delivery system, the associated cost, financing, stigmatisation, the physical environment and the individual needs that acted as barriers to and facilitators of the optimisation of oxygen therapy.Conclusion: Effective implementation of oxygen therapy in ILD requires more robust evidence to strengthen international guidelines, sustainable and equitable funding models, and improved oxygen delivery systems that meet the needs of users. Increased information and support for users will be critical to optimise the uptake and outcomes of this important therapy.Effective implementation of oxygen therapy in ILD requires more robust scientific evidence, technological innovations, equitable funding models and access to information and support to empower users. https://bit.ly/43B8l1R